Two Sigma Advisers
ARTL icon

Two Sigma Advisers’s Artelo Biosciences ARTL Stock Holding History

Two Sigma Advisers’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,142
Closed -$40.9K – 2382
2023
Q2 		$40.9K Sell
1,142
-373
-25% -$13.6K ﹤0.01% 2284
2023
Q1 		$63.2K Sell
1,515
-483
-24% -$24.5K ﹤0.01% 2428
2022
Q4 		$104K Buy
1,998
+50
+3% +$2.61K ﹤0.01% 2292
2022
Q3 		$121K Buy
+1,948
New +$157K ﹤0.01% 2281
2022
Q1 		– Sell
-59
Closed -$8K – 2726
2021
Q4 		$8K Sell
59
-73
-55% -$14.4K ﹤0.01% 2578
2021
Q3 		$28K Sell
132
-831
-86% -$211K ﹤0.01% 2396
2021
Q2 		$309K Buy
+963
New +$329K ﹤0.01% 2132

Other funds holding ARTL

HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Advisers's ARTL Position: Q3 2023 in Review

Two Sigma Advisers sold out of Artelo Biosciences (ARTL) in Q3 2023, closing a stake of 1,142 shares — an estimated $40.9K sold.

Two Sigma Advisers first reported a position in ARTL in Q2 2021 and held it in 7 quarters. The position peaked at $309K in Q2 2021. 8 funds tracked by Wall St. Rank hold ARTL as of Q3 2023.

  • Two Sigma Advisers reported no remaining Artelo Biosciences position as of Q3 2023 after selling out during the quarter.
  • Two Sigma Advisers sold 1,142 Artelo Biosciences shares in Q3 2023, an estimated $40.9K.
  • Two Sigma Advisers first reported a position in Artelo Biosciences in Q2 2021 and held it in 7 quarters.
  • Two Sigma Advisers's Artelo Biosciences position peaked at $309K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Artelo Biosciences as of Q3 2023.

Based on Two Sigma Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.